|
|
||||||||

*
Department of Medicine, Harvard Medical School and Charles A. Dana Research Institute, Harvard-Thorndike Laboratory, Division of Infectious Disease, Beth Israel Deaconess Medical Center, Boston, MA 02215; and
Division of Rheumatology, Immunology and Allergy, Department of Medicine, Brigham and Womens Hospital, Boston, MA 000000
Previously, we showed that soluble C1q bound specifically to CR1 on transfected cells. If the CR1-C1q interaction were to participate in immune complex clearance, then this interaction should support E adhesion. Using a tip plate adhesion assay, we found that immobilized C1q mediated adhesion of human E. E binding to C1q was specifically inhibited by polyclonal anti-CR1 Fab fragments. Intact C1 was not efficient as an adherence ligand until it was treated with EDTA or the C1 inhibitor to remove the C1r2C1s2 complex from C1, leaving C1q. Titration of C1q alone, C4b alone, and C1q + C4b indicated that the two complement ligands were additive in their ability to support CR1-mediated adhesion of E. Analysis of binding to immobilized CR1 using a BIAcore instrument documented that C1q, C4b, and C3b binding were independent events. Additionally, C1q-dependent binding of immune complexes and heat-aggregated IgG to E was documented. These experiments confirm that the immune adherence receptor in humans, CR1, is the single receptor for all of the opsonic ligands of complement, provide evidence for a single C1q binding site on LHR-D of CR1, and suggest that C1q may participate in immune clearance.
This article has been cited by other articles:
![]() |
I. Ghiran, A. M. Glodek, G. Weaver, L. B. Klickstein, and A. Nicholson-Weller Ligation of erythrocyte CR1 induces its clustering in complex with scaffolding protein FAP-1 Blood, October 15, 2008; 112(8): 3465 - 3473. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Ghumra, J.-P. Semblat, R. S. McIntosh, A. Raza, I. B. Rasmussen, R. Braathen, F.-E. Johansen, I. Sandlie, P. K. Mongini, J. A. Rowe, et al. Identification of Residues in the C{micro}4 Domain of Polymeric IgM Essential for Interaction with Plasmodium falciparum Erythrocyte Membrane Protein 1 (PfEMP1) J. Immunol., August 1, 2008; 181(3): 1988 - 2000. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Li, D. T. Glover, A. J. Szalai, S. K. Hollingshead, and D. E. Briles PspA and PspC Minimize Immune Adherence and Transfer of Pneumococci from Erythrocytes to Macrophages through Their Effects on Complement Activation Infect. Immun., December 1, 2007; 75(12): 5877 - 5885. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Horakova, O. Gasser, S. Sadallah, J. M. Inal, G. Bourgeois, I. Ziekau, T. Klimkait, and J. A. Schifferli Complement Mediates the Binding of HIV to Erythrocytes J. Immunol., September 15, 2004; 173(6): 4236 - 4241. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. J. Nauta, G. Castellano, W. Xu, A. M. Woltman, M. C. Borrias, M. R. Daha, C. van Kooten, and A. Roos Opsonization with C1q and Mannose-Binding Lectin Targets Apoptotic Cells to Dendritic Cells J. Immunol., September 1, 2004; 173(5): 3044 - 3050. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Tamano, H. Ohi, S. Sudo, and Y. Tomino Quantitative polymorphism of complement receptor type 1 (CR1) in patients undergoing haemodialysis Nephrol. Dial. Transplant., June 1, 2004; 19(6): 1467 - 1473. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Ghiran, L. B. Klickstein, and A. Nicholson-Weller Calreticulin Is at the Surface of Circulating Neutrophils and Uses CD59 as an Adaptor Molecule J. Biol. Chem., May 30, 2003; 278(23): 21024 - 21031. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Garratty, M. J. Telen, and L. D. Petz Red Cell Antigens as Functional Molecules and Obstacles to Transfusion Hematology, January 1, 2002; 2002(1): 445 - 462. [Abstract] [Full Text] |
||||
![]() |
N. A. Mabbott and M. E. Bruce The immunobiology of TSE diseases J. Gen. Virol., October 1, 2001; 82(10): 2307 - 2318. [Full Text] [PDF] |
||||
![]() |
I. Ghiran, S. F. Barbashov, L. B. Klickstein, S. W. Tas, J. C. Jensenius, and A. Nicholson-Weller Complement Receptor 1/CD35 Is a Receptor for Mannan-binding Lectin J. Exp. Med., December 18, 2000; 192(12): 1797 - 1808. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. Chen, S. B. Koralov, and G. Kelsoe Complement C4 Inhibits Systemic Autoimmunity through a Mechanism Independent of Complement Receptors CR1 and CR2 J. Exp. Med., November 6, 2000; 192(9): 1339 - 1352. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |